China Universal Asset Management Company’s Zevra Therapeutics ZVRA Stock Holding History

China Universal Asset Management Company’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$135K	Sell	9,408 -582	-6%	-$6.47K	0.01%	390
2026 Q1	$93.1K	Buy	9,990 +816	+9%	+$7.36K	0.01%	408
2025 Q4	$82.2K	Sell	9,174 -666	-7%	-$6.3K	0.01%	420
2025 Q3	$93.6K	Sell	9,840 -1,142	-10%	-$11.5K	0.01%	392
2025 Q2	$96.8K	Buy	10,982 +276	+3%	+$2.24K	0.01%	370
2025 Q1	$80.2K	Sell	10,706 -612	-5%	-$4.86K	0.01%	375
2024 Q4	$94.4K	Buy	+11,318	New	+$96.6K	0.01%	399
2022 Q4	–	Sell	-323	Closed	-$2K	–	475
2022 Q3	$2K	Buy	+323	New	+$1.83K	﹤0.01%	363

Other funds holding ZVRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RPCONE

Retirement Planning Company of New England Warwick, Rhode Island $278M AUM 38.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MAM

Mystic Asset Management Warwick, Rhode Island $468M AUM 30.94% 1-Year Est. Return

China Universal Asset Management Company's ZVRA Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Zevra Therapeutics (ZVRA) stake by 5.8% in Q2 2026, selling an estimated $6.47K and leaving 9,408 shares worth $135K. The position accounts for 0.01% of the portfolio, ranked #390.

China Universal Asset Management Company first reported a position in ZVRA in Q3 2022 and has held it in 8 quarters since. 82 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

China Universal Asset Management Company held 9,408 shares of Zevra Therapeutics worth $135K as of Q2 2026.
China Universal Asset Management Company sold 582 Zevra Therapeutics shares in Q2 2026, an estimated $6.47K.
Zevra Therapeutics made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #390 holding.
China Universal Asset Management Company first reported a position in Zevra Therapeutics in Q3 2022 and has held it in 8 quarters since.
82 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.